PubMed HealthSearch

PubMed · 39956121

Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM.

Oliver A Cornely·Rosanne Sprute·Matteo Bassetti·Sharon C-A Chen·Andreas H Groll·Oliver Kurzai·Cornelia Lass-Flörl·Luis Ostrosky-Zeichner·Riina Rautemaa-Richardson·Gunturu Revathi·Maria E Santolaya·P Lewis White·Ana Alastruey-Izquierdo·Maiken C Arendrup·John Baddley·Aleksandra Barac·Ronen Ben-Ami·Adrian J Brink·Jan H Grothe·Jesus Guinea·Ferry Hagen·Bruno Hochhegger·Martin Hoenigl·Shahid Husain·Kauser Jabeen·Henrik E Jensen·Souha S Kanj·Philipp Koehler·Thomas Lehrnbecher·Russell E Lewis·Jacques F Meis·M Hong Nguyen·Zoi D Pana·Peter-Michael Rath·Ilana Reinhold·Danila Seidel·Takahiro Takazono·Donald C Vinh·Sean X Zhang·Javier Afeltra·Abdullah M S Al-Hatmi·Amir Arastehfar·Sevtap Arikan-Akdagli·Felix Bongomin·Fabianne Carlesse·Methee Chayakulkeeree·Louis Y A Chai·Leili Chamani-Tabriz·Tom Chiller·Anuradha Chowdhary·Cornelius J Clancy·Arnaldo L Colombo·Andrea Cortegiani·Dora E Corzo Leon·Lubos Drgona·Anna Dudakova·Joveria Farooqi·Sara Gago·Macit Ilkit·Jeffrey D Jenks·Nikolai Klimko·Robert Krause·Anil Kumar·Katrien Lagrou·Michail S Lionakis·Badre E Lmimouni·Michael K Mansour·Joseph Meletiadis·Sibylle C Mellinghoff·Mervyn Mer·Malgorzata Mikulska·Philippe Montravers·Chin Fen Neoh·Volkan Ozenci·Livio Pagano·Peter Pappas·Thomas F Patterson·Pedro Puerta-Alcalde·Laman Rahimli·Sebastian Rahn·Emmanuel Roilides·Coleman Rotstein·Tamara Ruegamer·Raquel Sabino·Jon Salmanton-García·Ilan S Schwartz·Esther Segal·Neeraj Sidharthan·Tanu Singhal·Janos Sinko·Rajeev Soman·Andrej Spec·Joerg Steinmann·Jannik Stemler·Saad J Taj-Aldeen·Alida Fe Talento·George R Thompson·Christina Toebben·Hiram Villanueva-Lozano·Retno Wahyuningsih

Abstract

Candida species are the predominant cause of fungal infections in patients treated in hospital, contributing substantially to morbidity and mortality. Candidaemia and other forms of invasive candidiasis primarily affect patients who are immunocompromised or critically ill. In contrast, mucocutaneous forms of candidiasis, such as oral thrush and vulvovaginal candidiasis, can occur in otherwise healthy individuals. Although mucocutaneous candidiasis is generally not life-threatening, it can cause considerable discomfort, recurrent infections, and complications, particularly in patients with underlying conditions such as diabetes or in those taking immunosuppressive therapies. The rise of difficult-to-treat Candida infections is driven by new host factors and antifungal resistance. Pathogens, such as Candida auris (Candidozyma auris) and fluconazole-resistant Candida parapsilosis, pose serious global health risks. Recent taxonomic revisions have reclassified several Candida spp, potentially causing confusion in clinical practice. Current management guidelines are limited in scope, with poor coverage of emerging pathogens and new treatment options. In this Review, we provide updated recommendations for managing Candida infections, with detailed evidence summaries available in the appendix.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Oliver A Cornely, Rosanne Sprute, Matteo Bassetti, Sharon C-A Chen, Andreas H Groll, Oliver Kurzai, Cornelia Lass-Flörl, Luis Ostrosky-Zeichner, Riina Rautemaa-Richardson, Gunturu Revathi, Maria E Santolaya, P Lewis White, Ana Alastruey-Izquierdo, Maiken C Arendrup, John Baddley, Aleksandra Barac, Ronen Ben-Ami, Adrian J Brink, Jan H Grothe, Jesus Guinea, Ferry Hagen, Bruno Hochhegger, Martin Hoenigl, Shahid Husain, Kauser Jabeen, Henrik E Jensen, Souha S Kanj, Philipp Koehler, Thomas Lehrnbecher, Russell E Lewis, Jacques F Meis, M Hong Nguyen, Zoi D Pana, Peter-Michael Rath, Ilana Reinhold, Danila Seidel, Takahiro Takazono, Donald C Vinh, Sean X Zhang, Javier Afeltra, Abdullah M S Al-Hatmi, Amir Arastehfar, Sevtap Arikan-Akdagli, Felix Bongomin, Fabianne Carlesse, Methee Chayakulkeeree, Louis Y A Chai, Leili Chamani-Tabriz, Tom Chiller, Anuradha Chowdhary, Cornelius J Clancy, Arnaldo L Colombo, Andrea Cortegiani, Dora E Corzo Leon, Lubos Drgona, Anna Dudakova, Joveria Farooqi, Sara Gago, Macit Ilkit, Jeffrey D Jenks, Nikolai Klimko, Robert Krause, Anil Kumar, Katrien Lagrou, Michail S Lionakis, Badre E Lmimouni, Michael K Mansour, Joseph Meletiadis, Sibylle C Mellinghoff, Mervyn Mer, Malgorzata Mikulska, Philippe Montravers, Chin Fen Neoh, Volkan Ozenci, Livio Pagano, Peter Pappas, Thomas F Patterson, Pedro Puerta-Alcalde, Laman Rahimli, Sebastian Rahn, Emmanuel Roilides, Coleman Rotstein, Tamara Ruegamer, Raquel Sabino, Jon Salmanton-García, Ilan S Schwartz, Esther Segal, Neeraj Sidharthan, Tanu Singhal, Janos Sinko, Rajeev Soman, Andrej Spec, Joerg Steinmann, Jannik Stemler, Saad J Taj-Aldeen, Alida Fe Talento, George R Thompson, Christina Toebben, Hiram Villanueva-Lozano, Retno Wahyuningsih. 2025-02-13. Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM.. https://doi.org/10.1016/s1473-3099(24)00749-7

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Global Genomic Surveillance.

Global genomic surveillance has emerged as a foundational pillar of public health in the twenty-first century, enabling real-time tracking of pathogen evolution and informing outbreak response. This chapter examines the strategic architecture of global genomic surveillance, focusing on its application to arboviruses such as chikungunya virus (CHIKV). It explores the integration of genomic data with epidemiological, clinical, and environmental information within a One Health framework, while addressing critical challenges in governance, equity, and interoperability. The discussion covers the entire genomic surveillance workflow, from sample collection and sequencing to bioinformatic analysis and phylogenetic inference, and highlights the transformative role of artificial intelligence (AI) in predictive surveillance. By analyzing global initiatives, operational barriers, and emerging technologies, this chapter underscores the necessity of sustainable, equitable, and interoperable genomic systems to proactively address current and future infectious disease threats.

Humans

Systematic Dissection of Key Driver Perturbation Signatures in Single Cells via ECCITE-seq.

CRISPR screens, such as expanded CRISPR-compatible cellular indexing of transcriptomes and epitopes by sequencing (ECCITE-seq), enable the simultaneous measurement of transcriptomes, gRNA identity, and cell-surface protein expression at single-cell resolution to systematically interrogate gene function. This platform provides a powerful and scalable experimental approach for validating disease-associated regulators identified by large-scale association studies and other computational methods, including network-based analyses of multi-omics data. Here, as an example application, we describe an ECCITE-seq framework to characterize the transcriptomic consequences of perturbing multiple neuronal key driver genes associated with Alzheimer's disease (AD) in human-induced pluripotent stem cell (hiPSC)-derived neurons. More broadly, by integrating customized pooled gRNA libraries with different CRISPR effectors across multiple cell types, this approach allows for the assessment of the regulatory impact of candidate genes implicated in development and disease processes.

Humans

Identification of Genome-Wide Chromatin Structural Aberration in Cancer by Hi-C Analysis.

Aberrant three-dimensional genome organization is a hallmark of cancer, often driving oncogene activation through mechanisms such as enhancer hijacking. High-throughput chromosome conformation capture (Hi-C) maps these interactions on a genome-wide scale. Unlike earlier dilution-based methods, in situ Hi-C performs proximity ligation within intact nuclei, minimizing random ligation noise and enabling fine-scale structure detection. This chapter describes an optimized in situ Hi-C protocol tailored for cancer cell lines using MboI digestion and biotin-mediated pull-down to generate high-complexity libraries. We further outline a computational workflow that extends beyond standard topological mapping of compartments and topologically associating domains to identify cancer-specific aberrations. Specifically, we focus on detecting chromosomal rearrangements (structural variants) and characterizing the distinct circular topology of extrachromosomal DNA. This integrated experimental and analytical framework provides the necessary tools to dissect the spatial dysregulation underlying tumor evolution.

Humans